EditorialHepatobiliary Surg Nutr2026
Editorial for PREOPANC-2, a multicenter, open-label, phase 3 randomized trial comparing neoadjuvant FOLFIRINOX vs. neoadjuvant gemcitabine based chemoradiotherapy in resectable and borderline resectable pancreatic cancer.
- Journal
- Hepatobiliary Surg Nutr
- Published
- 3 September 2026
- Citations
- 0
- Type
- Editorial
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try